Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
02.10.25
/
50%
€346.50
Target price
02.10.26
€489.84
Performance (%)
35.44%
Price
21.08.26
€469.30
Summary
This prediction is currently active. With a performance of 35.44% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 02.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 7.416% | 7.416% |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by Citigroup_Inc_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by analysts at Citigroup Inc. from $550.00 to $575.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€435.00
10.03.26
10.03.26
€503.22
10.03.27
10.03.27
7.89%
21.08.26
21.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.80
14.11.24
14.11.24
€545.96
14.11.25
14.11.25
-19.47%
15.11.25
15.11.25